The company, which listed on the Nasdaq April 23 as GNLN, reported a net loss of $17.7 million for the quarter.
The loss stemmed, in part, from costs associated with Greenlane’s expansion as a public company.
For more details, click here.
Be at the forefront of cannabis and psychedelics science and innovation. Register by March 14 & Save $100 on tickets to The Emerald Conference by MJBiz Science, April 1-3 in San Diego.
The company, which listed on the Nasdaq April 23 as GNLN, reported a net loss of $17.7 million for the quarter.
The loss stemmed, in part, from costs associated with Greenlane’s expansion as a public company.
For more details, click here.